Ledger.Open graph →
SEC Form D · filed September 5, 2019

Immutrix Therapeutics, Inc

Offering
$2.0M
Sold
$450K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
RAPID CITY, SD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Vincent R. O'Donnell · Auburndale, MADirectorEdwin V. Finch · Birmingham, ALExec · DirectorJoan B. Berkowitz · New York, NYExec · DirectorMichael Novogratz · New York, NYDirectorKarla Bodden · George Town, Grand Cayman, Cayman IslandsDirectorJonathan Crowther · Grand Cayman, Cayman IslandsExec · DirectorChris Joyce · London, United KingdomDirectorEdward Herring · Dallas, TXExec · DirectorJames L. Scull · Rapid City, SDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗